Profile | GDS4284 / 1562903_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4863.19 | 93 |
GSM687648 | Patient 402 control | 5939.34 | 94 |
GSM687653 | Patient 403 control | 2796.78 | 88 |
GSM687658 | Patient 404 control | 4901.84 | 93 |
GSM687663 | Patient 411 control | 6333.34 | 95 |
GSM687668 | Patient 422 control | 5576.63 | 94 |
GSM687673 | Patient 424 control | 6497.72 | 95 |
GSM687678 | Patient 425 control | 6541.77 | 95 |
GSM687683 | Patient 427 control | 9731.03 | 97 |
GSM687688 | Patient 428 control | 2570.53 | 87 |
GSM687695 | Patient 441 control | 20984.1 | 98 |
GSM687699 | Patient 443 control | 7298.1 | 96 |
GSM687704 | Patient 444 control | 6039.81 | 95 |
GSM687707 | Patient 448 control | 4880.73 | 93 |
GSM687712 | Patient 449 control | 7018.35 | 95 |
GSM687719 | Patient 450 control | 9298.42 | 97 |
GSM687724 | Patient 451 control | 7028.71 | 95 |
GSM687728 | Patient 452 control | 5338.9 | 94 |
GSM687646 | Patient 401 treated 24h | 3469.66 | 90 |
GSM687649 | Patient 402 treated 24h | 3933.18 | 91 |
GSM687665 | Patient 411 treated 24h | 10397.9 | 97 |
GSM687651 | Patient 402 treated 4 weeks | 6041.32 | 95 |
GSM687667 | Patient 411 treated 4 weeks | 4745.9 | 93 |
GSM687670 | Patient 422 treated 24h | 6607.3 | 95 |
GSM687671 | Patient 422 treated 4 weeks | 4112.78 | 92 |
GSM687654 | Patient 403 treated 24h | 4445.1 | 92 |
GSM687675 | Patient 424 treated 24h | 7789.33 | 96 |
GSM687685 | Patient 427 treated 24h | 5621.45 | 94 |
GSM687656 | Patient 403 treated 4 weeks | 3432.97 | 90 |
GSM687677 | Patient 424 treated 4 weeks | 4936.03 | 93 |
GSM687687 | Patient 427 treated 4 weeks | 1744.23 | 82 |
GSM687692 | Patient 428 treated 4h | 3747.88 | 91 |
GSM687716 | Patient 449 treated 4h | 3188.28 | 89 |
GSM687722 | Patient 450 treated 4h | 13746.6 | 98 |
GSM687680 | Patient 425 treated 24h | 6920.14 | 95 |
GSM687690 | Patient 428 treated 24h | 4145.78 | 92 |
GSM687700 | Patient 443 treated 24h | 19440.6 | 99 |
GSM687705 | Patient 444 treated 24h | 4577.47 | 93 |
GSM687714 | Patient 449 treated 24h | 5360.6 | 94 |
GSM687721 | Patient 450 treated 24h | 14682.3 | 98 |
GSM687682 | Patient 425 treated 4 weeks | 4187.86 | 92 |
GSM687694 | Patient 428 treated 4 weeks | 3179.57 | 89 |
GSM687702 | Patient 443 treated 4 weeks | 9633.9 | 97 |
GSM687718 | Patient 449 treated 4 weeks | 3927.71 | 91 |
GSM687723 | Patient 450 treated 4 weeks | 8473.88 | 96 |
GSM687661 | Patient 404 treated 4h | 7710.82 | 96 |
GSM687710 | Patient 448 treated 4h | 4396.75 | 92 |
GSM687726 | Patient 451 treated 4h | 6656.44 | 95 |
GSM687730 | Patient 452 treated 4h | 16268 | 98 |
GSM687660 | Patient 404 treated 24h | 15679.9 | 98 |
GSM687697 | Patient 441 treated 24h | 15122.9 | 98 |
GSM687709 | Patient 448 treated 24h | 5144.87 | 93 |
GSM687725 | Patient 451 treated 24h | 10068.7 | 97 |
GSM687729 | Patient 452 treated 24h | 12983.3 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 5091.97 | 94 |
GSM687731 | Patient 452 treated 4 weeks | 6222.99 | 95 |